Fred is correct in this situation. Its time for some people to perhaps see the full picture instead of only seeing what they want to see. There is another offering coming. How low? I guess we'll have to wait and see.
So you think Mallinkrodt is incapable of securing their anticipated market share of SeroquelXR sales? You think PAR is also incapable of securing their anticipated market share of FocalinXR sales?
Doom and gloom has to be rooted in some logical basis fred which I'm sure you must agree?
So what say you...what reason do you have to think PAR and Mallinkrodt are suddenly incapable of gaining their anticipated market share of FocalinXR and SeroquelXR sales?